{
    "cancelStatus": "0",
    "licStatus": "1",
    "cancelDate": null,
    "cancelReason": [],
    "otherCancelReason": "",
    "licid": "52027818",
    "licUnit": "1",
    "validDate": "2030-02-13 00:00:00.000",
    "issueDate": "2020-02-13 00:00:00.000",
    "oriIssueDate": null,
    "licKind": "10",
    "oldLicid": null,
    "certNo": "DHA05202781806",
    "prodNameC": "頭孢泰新鈉",
    "prodNameE": "Cefotaxime Sodium",
    "indicationsName": [
        "抗生素"
    ],
    "does": "0040",
    "packageUnit": [
        {
            "packageSpec": "",
            "packageUnit": "4C"
        }
    ],
    "medMCode": "01",
    "maMedCode": "",
    "medDCode": "E",
    "mainCategory": "E",
    "drBaseId": "B0CFACB5-C4D3-486A-9E35-33A1FE17C0B0",
    "subCategory": [],
    "ingredientsDesc": [
        "INN: Cefotaxime Sodium\r\nMolecular formular: C16H16N5NaO7S2\r\nContent: 96.0 per cent to 102.0 per cent (anhydrous substance)"
    ],
    "restraintItemsCode": [
        "02"
    ],
    "applicantName": "義大國際有限公司",
    "applicantAddr": "桃園市桃園區自強路31號",
    "medClass": null,
    "efficacy": " ",
    "mdFormat": null,
    "productAnnotation": "",
    "mdKind": [],
    "monitorDate": null,
    "licidNew": null,
    "licidOld": null,
    "factoryDtoList": [
        {
            "id": "385800B6-C149-4AEB-BAA0-D5B1AB1D6CD1",
            "factoryCode": "1",
            "factoryName": "KYONGBO PHARMACEUTICAL CO., LTD.",
            "factoryAddr": "174 SIROK-RO, ASAN-SI, CHUNGCHEONGNAM-DO, REPUBLIC OF KOREA",
            "factoryCompanyAddr": "",
            "countryCode": "KR",
            "processCode": [],
            "processCodeStr": null,
            "factoryKind": "M",
            "factoryNo": "FKR0087200",
            "factoryInfo": null,
            "qsd": null,
            "qsdList": [],
            "factoryMadeIn": null
        }
    ],
    "ingredientsDtoList": [
        {
            "ingredientsKind": "1",
            "ingredientsCode": null,
            "ingredientsName": "INN: Cefotaxime Sodium\r\nMolecular formular: C16H16N5NaO7S2\r\nContent: 96.0 per cent to 102.0 per cent (anhydrous substance)",
            "ingredientsDesc": "INN: Cefotaxime Sodium\r\nMolecular formular: C16H16N5NaO7S2\r\nContent: 96.0 per cent to 102.0 per cent (anhydrous substance)",
            "concentDesc": null,
            "concent": null,
            "concentUnit": null,
            "seq": "1",
            "prescription_seq": "1",
            "prescription_Kind": "2"
        }
    ],
    "authDtoList": [],
    "iomDtoList": [],
    "changeDtoList": [],
    "atcList": [
        {
            "isMain": "1",
            "atcCode": "J01DD01"
        }
    ],
    "licBaseId": "2F233F31-8673-422A-A309-A325696CFD98"
}